CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
June 13 marks Global Fatty Liver Day, a vital initiative to raise awareness about a disease that affects roughly 2 billion people worldwide. At ENDRA Life Sciences, we're pioneering Thermo Acoustic Enhanced UltraSound (TAEUS®) to assess liver fat non-invasively at 1/40th the cost of an MRI, at the point of patient care. Join us in our mission to broaden access to better healthcare and advance the diagnosis and understanding of steatotic liver disease (SLD). #FattyLiverDay #HealthcareInnovation #ENDRALifeSciences #TAEUS
